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Abstract
In dendritic cell (DC)-CD4
+ T cell interaction, Notch signaling has been implicated in the CD4
+ T cell activation, proliferation,
and subset differentiation. However, there has been a lot of debate on the exact role of Notch signaling. Here, we observed
that expression of Mind bomb-1 (Mib1), a critical regulator of Notch ligands for the activation of Notch signaling, increases
gradually as precursor cells differentiate into DCs in mice. To clarify the role of Mib1 in DC-CD4
+ T cell interactions, we
generated Mib1-null bone marrow–derived DCs. These cells readily expressed Notch ligands but failed to initiate Notch
activation in the adjacent cells. Nevertheless, Mib1-null DCs were able to prime the activation and proliferation of CD4
+ T
cells, suggesting that Notch activation in CD4
+ T cells is not required for these processes. Intriguingly, stimulation of CD4
+ T
cells with Mib1-null DCs resulted in dramatically diminished Th2 cell populations, while preserving Th1 cell populations,
both in vitro and in vivo. Our results demonstrate that Mib1 in DCs is critical for the activation of Notch signaling in CD4
+ T
cells, and Notch signaling reinforces Th2 differentiation, but is not required for the activation or proliferation of the CD4
+ T
cells.
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Introduction
Dendritic cells (DCs) play a pivotal role as APCs in CD4
+ T cell
immune responses. Recently, Notch signaling has been implicated
in DC-CD4
+ T cell interaction, leading to activation, proliferation,
and subset differentiation of CD4
+ T cells. However, various
experimental approaches have yielded disparate results and a
conclusive consensus has not been reached yet [1,2,3]. Notch
signaling is a highly conserved intercellular signaling pathway that
regulates multiple cell-fate decisions. In mammals, Notch signaling
is mediated by interactions between the four Notch receptors
(Notch1-Notch4) and their ligands, Delta-like ligand-1 (Dll1), Dll3,
Dll4, Jagged-1 (Jag1), and Jag2. The ligation to Notch receptors
results in sequential proteolytic cleavages and release of the Notch
intracellular domain (NICD), which translocates into the nucleus
and functions as a transcriptional regulator for various target genes
such as Hes and Hey [3,4].
DCs and CD4
+ T cells express Notch ligands, Dll1, Dll4, Jag1,
and Jag2, and Notch receptors, Notch1 and Notch2, respectively,
suggesting that Notch signaling is activated during DC-CD4
+ T cell
interaction [5,6]. Several studies have reported that Notch signaling
augments CD4
+ T cell activation and proliferation [5,7,8], while
other studies have suggested that Notch signaling negatively
regulates T cell activation [9,10]. There is more controversy on
the role of Notch signaling with regard to Th differentiation. Many
studieshave reported that activation ofNotchsignalingpromotesT-
bet-mediated Th1 differentiation [7,11,12]. However, several other
studies have suggested that Notch signaling is critical for Th2
differentiation but dispensable for Th1 differentiation [6,13,14].
Moreover, some studies have shown that Notch signaling cannot
initiate Th1 or Th2 differentiation [15,16]. These apparent
inconsistencies among the many studies could be due to the
nonphysiological practice of using chemicals and cytokines to
stimulate or inhibit TCR and Notch signaling pathways [1,2,3]. In
addition, the potential side effects of artificial APCs or of the direct
manipulation of CD4
+ T cells have not been well addressed. Thus,
the exact role of Notch signaling in CD4
+ T cells needs to be further
determined by a novel genetic approach that minimizes the possible
artifacts and side effects.
Recently, it was revealed that ligand internalization by
endocytosis in the signal-sending cells is absolutely required for
the initiation of Notch activation [17]. Four different E3 ubiquitin
ligases, Mind bomb-1 (Mib1), Mib2, Neuralized-1 (Neur1), and
Neur2 have been shown to regulate the endocytosis of Notch
ligands in mice [18,19,20,21,22]; however, only Mib1 has been
shown to play an obligatory role in the activation of Jag- as well as
Dll-mediated Notch activation in vivo [23]. Therefore, cell-type-
specific Mib1 conditional knockout mice have been known as
excellent models for elucidating the role of Notch signaling in
various contexts [24,25,26,27,28,29].
To clarify the role of Notch signaling in CD4
+ T cell immune
responses, we generated mice in which Mib1 was conditionally
inactivated under the control of the interferon-inducible promoter
Mx1 (Mx1-Cre;Mib1
f/f) [30]. The Mib1-null DCs derived from the
bone marrow (BM) of the Mx1-Cre;Mib1
f/f mice failed to activate
Notch signaling in Notch1-expressing C2C12 cells and in naı ¨ve
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+ T cells. Nevertheless, the CD4
+ T cells stimulated by Mib1-
null DCs possessed comparable levels of the activation markers
CD25, CD44, and CD69 and normal proliferation kinetics.
Moreover, Th1 differentiation, which yields IFN-c remained
intact in the CD4
+ T cells stimulated by Mib1-null DCs; this
showed that Notch signaling in the context of DC-CD4
+ T cell
interaction is not required for these processes. In contrast, Th2
differentiation, which yields IL-4, was impaired dramatically both
in vitro and in vivo. These data clearly indicate that Mib1-initiated
Notch activation has a specific role in the promotion of Th2
differentiation.
Materials and Methods
Ethics Statement
All animal experiments were done with the approval of the
ethical committees at the Seoul National University.
Mice
The Mib1
f/f mice were generated previously [23]. Mx1-Cre
transgenic mice, OT-II TCR transgenic mice, and CD45.1
congenic mice were purchased from The Jackson Laboratory.
For all experiments, we bred Mx1-Cre;Mib1
f/f mice with Mib1
f/f
mice and examined the pups. To remove the floxed allele, 8-week-
old Mx1-Cre;Mib1
f/f and Mib1
f/f mice received 4 i.p. injections of
300 mg of polyinosinic-polycytidylic acid (pIpC, Amersham
Biosciences) at 2-day intervals. All the mouse lines were bred
onto a C57BL/6 background (backcrossed more than 10
generations) and were maintained under specific pathogen-free
conditions at the Seoul National University Animal Facility.
Preparation of BM-derived DCs
BM cells were obtained from the tibias and femurs of mice 1
month after the last pIpC injection and 7.5610
5 cells were plated
in non-culture treated 6-well plates in 2 ml of RPMI and 10%
heat-inactivated FBS in the presence of 20 ng/ml of recombinant
GM-CSF (Peprotech). On day 4, an equal amount of media
containing rGM-CSF was added. On days 7 and 9, half of the
media was replaced with fresh media. BM-derived DCs were
harvested on day 9 and yielded 90,95% CD11c
+ cells. For DC
stimulation, 1 mg/ml of LPS (Sigma-Aldrich) was added and
incubated for 24 h.
Preparation of naive CD4
+ T cells
Lymph-node cells were collected from 8-week-old OT-II or
SMARTA mice and incubated with biotin-conjugated Abs, anti-
B220, CD8, CD11b, CD11c, CD19, CD25, CD69, Dx5, Gr-1,
and Ter119 (all Abs were purchased from Biolegend). Untouched
naive CD4
+ T cells were negatively isolated by using streptavidin-
coated magnetic beads (Invitrogen) or cell sorting with FACS Aria
II (BD), which yielded greater than 95% purity.
Isolation of DC precursors in BM and flow cytometry
BM precursors of classical spleen DC were isolated by FACS
Aria II (BD), as reported previously [31]. Briefly, whole BM cells
from 8-week-old C57BL/6 mice were stained with anti-CX3CR1-
FITC, CD115-PE, CD135-APC, cKit-APC/Cy7, and Lin (CD3,
CD19, NK1.1, Ter119, B220, CD11c, CD11b, and Gr1)-biotin
Abs for MP (Lin
2, Flt3
+,cKit
hiCX3CR1
2), MDP (Lin
2, Flt3
+,
cKit
+, CX3CR1
+), and CDP (Lin
2, Flt3
+, cKit
lo, CD115
+,
CX3CR1
+) or anti-SIRPa-FITC, I-A
b-PE, CD135-APC,
CD11c-APC/Cy7, and Lin2 (CD3, CD19, NK1.1, Ter119, and
B220)-biotin Abs for pre-cDC (Lin2
2, CD11c
+, I-A
b2, Flt3
+,
SIRPa
lo). Streptavidin-PerCP was used as a secondary reagent.
Rabbit polyclonal Abs raised against CX3CR1 (Abcam) were
conjugated to FITC by using the EasyLink FITC conjugation Kit
(Abcam). All other Abs were obtained from Biolegend, except for
the PE-conjugated anti-Jag1 Ab (Lifespan biosciences).
In vitro experiments
The LPS-stimulated DCs derived from Mib1
f/f and Mx1-
Cre;Mib1
f/f mice were pretreated with 10 mg/ml of OVA323–339 or
GP61–80 peptides for 6 h. Naı ¨ve CD4
+ T cells (1610
6) were
cultured with peptide-pretreated DCs (1610
5). After 5 days of
incubation, cells were re-stimulated with 50 ng/ml of PMA
(Sigma-Aldrich) and 0.5 mM ionomycin (Sigma-Aldrich) for 6 h
in the presence of 2 mM monensin (Sigma-Aldrich). Cells were
washed, fixed in 2% paraformaldehyde, and permeabilized in
0.5% saponin (Sigma-Aldrich). A neutralizing anti-IFN-c Ab
(XMG1.2, BD Pharmingen) was treated (10 mg/ml) for an
experiment. For ELISA assays, viable T cells were harvested
and equal numbers of cells per group were re-stimulated with
1 mg/ml plate-bound anti-CD3. The supernatants were removed
after 48 h, and cytokine concentrations were determined by
ELISA (OptEIA, BD). 5, 6-carboxyfluorescein diacetate succini-
midyl ester (CFSE) labeling was performed as described previously
[5]. For RT-PCR analyses, RNA was extracted from the
negatively purified CD4
+ T cells by using the RNeasy Micro kit
(QIAGEN), according to the manufacturer’s instructions. The
isolated RNA was converted into cDNA by using Promega’s RT
system (Promega) with oligo-dT priming. The cDNAs from
specific mRNA transcripts were quantified using quantitative
real-time RT-PCR (Applied Biosystems) and SYBR Green
technology (SYBR Premix Ex Taq, Takara). b-Actin was used
as an internal control. The primer information will be provided on
request. Protein extraction and western blot analyses were
performed as described previously [18]. For the CBF-luciferase
(luc) assay, the 86WT or MT CBF-luc vectors were transfected
into C2C12-Notch1 cells with pRL-TK vector using Lipofecta-
mine (Invitrogen) as previously reported [26]. Luc activities were
measured with a Dual Luciferase kit (Promega).
Adoptive transfer experiment
1610
6 OT-II naive CD4
+ T cells were intravenously transferred
into CD45.1 recipient mice. After 24 h, the mice were
intraperitoneally injected with 5610
5 peptide-preloaded DCs
from Mib1
f/f or Mx1-Cre;Mib1
f/f mice. Seven days after the
injection, splenocytes were harvested, resuspended at 1610
7/ml,
and restimulated for 6 h with 10 mg/ml OVA323–339 in the
presence of 50 U/ml human rIL-2 (Biolegend). Th cell popula-
tions in the OT-II CD4
+ T cells (CD45.2
+) and cytokine
concentrations in the media were determined by flow cytometry
and ELISA, respectively.
Statistical analysis
All values are given as mean 6 SD. Statistical comparisons were
made by 2-tailed unpaired Student t test. A P value of less than
0.05 was considered statistically significant.
Results
Expression of ligands and E3 ligases in DCs for Notch
signaling
First, we examined the expression of Notch ligands and their
regulators, E3 ubiquitin ligases in BM-derived DCs. As reported
previously [6], Jag1 and Jag2, but not Dll1 and Dll4, were
substantially expressed (Fig. 1A). Among the four E3 ligases, Mib1
was dominantly expressed, whereas Mib2, Neur1, and Neur2 were
Mib1 in DCs Regulates Notch-Mediated Th2
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the expression of these E3 ligases are further induced by TLR
stimulation. Although the transcripts and surface expression of
Jag1, Dll1, and Dll4 increased in response to LPS treatment in
accordance with a previous report [6], the expression profiles of
Mib1, Mib2, Neur1, and Neur2 were not influenced significantly
(Fig. 1C and D), which suggests that the expressions of the Notch
ligands and E3 ligases are regulated by distinct mechanisms.
Since among the E3 ligases, Mib1 is dominantly and
constitutively expressed in BM-derived DCs, we investigated
whether its expression is increased during BM-cell culture
containing rGM-CSF. Interestingly, the Mib1 expression was
increased dramatically according to the duration of culture (Fig. 1E
and F), suggesting that Mib1 expression increases as the precursor
cells differentiate into DCs. Consistent with mRNA transcripts,
Mib1 protein expression was not induced any further in response
to LPS (Fig. 1E). To confirm Mib1 expression during DC
differentiation in vivo, we isolated DC precursors at various
developmental stages from mice. In the mouse BM, myeloid
progenitors (MPs) first differentiate into macrophage and DC
precursors (MDPs), then into common DC precursors (CDPs), and
finally into committed precursors of classical spleen DC (pre-
cDCs) [31]. Interestingly, throughout this progression, the relative
Mib1 transcript levels increased progressively (Fig. 1G). Taken
together, these results show that Mib1 expression in DCs increases
with progress in the development, suggesting a potential role of
Mib1 in peripheral DCs.
Mib1-null DCs show normal development and Notch
ligands expression
To investigate the role of Mib1 in DC-mediated immune
responses, we inactivated Mib1 in hematopoietic systems,
Figure 1. Expression of ligands and E3 ligases for Notch signaling in DCs. A and B, Semi-quantitative RT-PCR analyses of Notch ligands (A)
and E3 ubiquitin ligases (B) in BM-derived DCs prior to LPS stimulation. Serial 2-fold dilutions of PCR products were electrophoresed in agarose gel C,
Quantitative real-time RT-PCR analysis of ligands and E3 ligases in DCs before (None) and after 24 h of LPS stimulation (Sti). The results are
representative of more than five independent experiments. D, Flow cytometry analysis for Notch ligands in DCs. IgG, Armenian hamster IgG isotype
control; None, DCs before LPS stimulation; Sti, DCs after LPS stimulation. Results are representative of three independent experiments. E, Western blot
analysis of Mib1 in BM culture with rGM-CSF on days 5, 7, and 9, and 24 h after LPS treatment on day9 (Sti). F, Quantitative real-time RT-PCR analysis
of Mib1 in BM culture with rGM-CSF on days 5, 7, and 9. G, Quantitative real-time RT-PCR analysis of Mib1 in the BM precursors of classical spleen DC.
MP, myeloid progenitor; MDP, macrophage and DC precursor; CDP, common DC precursor; pre-cDC, committed precursors of classical spleen DC.
Results are representative of three independent experiments. Data represent mean 6 SD; *, P,0.05.
doi:10.1371/journal.pone.0036359.g001
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(Mib1
f/f) with Mx1-Cre transgenic mice; this enabled the expression
of Cre recombinase in response to pIpC [23,25,30]. The mRNA
and protein expression of Mib1 disappeared in the BM-derived
DCs that originated from Mx1-Cre;Mib1
f/f mice (Fig. 2A and B).
Although several studies have implicated Notch signaling at
various stages of DC generation and maturation [3,32], Mib1-null
DCs were derived from BM hematopoietic precursors easily and
displayed comparable levels of the maturation markers CD40,
CD80, CD86, and MHC-II, both before and after LPS
stimulation (Fig. 2C). This results show that Mib1 is dispensable
for DC development in a cell-autonomous manner.
Next, we examined the expression of Notch ligands in Mib1-
null DCs. The transcript levels for Notch ligands in Mib1-null DCs
were comparable to those in control (Mib1
f/f) DCs (Fig. 2D).
However, Mib1-null DCs showed accumulation of surface Jag1
and Jag2 proteins (Fig. 2E); this finding is consistent with those of
previous studies, which reported that impaired endocytosis of
Notch ligands resulted in the accumulation of Notch ligands on the
cell surface [25,33,34]. These data showed that Mx1-Cre;Mib1
f/f
DCs, in which Mib1 is completely deleted, exhibited intact DC
phenotypes including Notch ligands expression.
Mib1-null DCs cannot trigger Notch signaling in adjacent
cells
To determine whether Mib1-null DCs were capable of
triggering the activation of Notch signaling in the adjacent cells,
we transfected Notch1-expressing C2C12 cells with WT and MT
CBF-luc constructs [26] and co-cultured the transfected cells with
control and Mib1-null DCs. Notably, Mib1-null DCs failed to
induce CBF-luc activity (Fig. 3A). Next, we co-cultured purified
OT-II naive CD4
+ T cells with OVA323–339 peptide-loaded
control and Mib1-null DCs. As a result, we observed strikingly
increased NICD in the CD4
+ T cells cultured with control DCs,
Figure 2. Generation of Mib1-null DCs. A and B, Quantitative real-time RT-PCR (A) and western blot (B) analyses of Mib1 in DCs from Mib1
f/f or
Mx1-Cre;Mib1
f/f mice. C, Flow cytometry analysis for DC marker, CD11c, costimulatory molecules, CD40, CD80 (B7.1), and CD86 (B7.2), and MHC II (I-A
b)
in Mib1
f/f or Mx1-Cre;Mib1
f/f DCs before (None, gray-filled histogram) or after LPS stimulation (Sti, black line). Numbers on flow cytometry
plots represent the mean percentage of cells 6 SD. D, Quantitative real-time RT-PCR analysis of Notch ligands in LPS-stimulated DCs from Mib1
f/f and
Mx1-Cre;Mib1
f/f mice. Results are representative of three independent experiments. E, Flow cytometry analysis for Jag1 and Jag2 in Mib1
f/f or
Mx1-Cre;Mib1
f/f DCs. Numbers indicate the relative median fluorescence intensities of IgG isotype control (IgG, gray-filled histogram), DCs before LPS
stimulation (None, dotted line), and DCs after LPS stimulation (Sti, black line), respectively, in each plots. Data represent mean 6 SD.
doi:10.1371/journal.pone.0036359.g002
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+ T cells cultured with Mib1-null DCs (Fig. 3B).
Moreover, the expressions of Notch target genes, Hes1 and Hes5,
in CD4
+ T cells were not markedly induced by Mib1-null DCs
(Fig. 3C). Collectively, ablation of Mib1 in DCs led to incapability
of Notch signaling activation, in spite of normal or even elevated
levels of Notch ligands.
Mib1-null DCs readily induce the activation and
proliferation of CD4
+ T cells
To examine whether Mib1 ablation in DCs influence CD4
+ T
cell activation and proliferation, we further analyzed OT-II CD4
+
T cells cultured with control or Mib1-null DCs. Intriguingly,
however, Mib1-null DCs readily induced upregulation of T-cell
activation markers CD25, CD44, and CD69, similar to the control
DCs (Fig. 4 A and B). Moreover, the proliferation kinetics of CD4
+
T cells cultured with the control or Mib1-null DCs were also
comparable, as shown by CFSE dilution (Fig. 4 B). This suggested
that CD4
+ T cells can be readily activated and proliferate in the
absence of Notch activation via interaction with DCs.
Mib1-null DCs impair in vitro Th2 differentiation
To investigate whether Mib1-null DCs are able to induce Th1/
2 differentiation, we performed intracellular cytokine staining for
IFN-c and IL-4 in OT-II CD4
+ T cells cultured with DCs. As a
result, the percentage of IFN-c-expressing cells was comparable
between the control and Mib1-null DCs; however, the percentage
of IL-4-expressing cells was markedly decreased in Mib1-null DCs
(Fig. 5A and B). The CD4
+ T cells stimulated by Mib1-null DCs
also exhibited decreased IL-4 production when subjected to
Figure 3. Mib1-null DCs fail to activate Notch signaling. A, LPS-
stimulated Mib1
f/f or Mx1-Cre;Mib1
f/f DCs were cultured with Notch1-
expressing C2C12 cells transfected with WT or MT CBF luciferase
constructs, and 24 h after the coculture, luciferase activity was
measured. Results are representative of two independent experiments.
B, Western blot analysis of Notch1 ICD (NICD) in negatively purified OT-
II CD4
+ T cells before (None) and 6 h after coculture with peptide-
pretreated Mib1
f/f or Mx1-Cre;Mib1
f/f DCs. C, Quantitative real-time RT-
PCR analysis of Notch target genes, Hes1 and Hes5, in CD4
+ T cells
before (None) and after coculture with Mib1
f/f or Mx1-Cre;Mib1
f/f DCs.
Results are representative of three independent experiments. Data
represent mean 6 SD; *, P,0.05; **, P,0.001.
doi:10.1371/journal.pone.0036359.g003
Figure 4. Preserved activation and proliferation of Notch-inactivated CD4
+ T cells. A, Flow cytometry analysis for T cell activation markers,
CD44 and CD69, in purified CD4
+ T cells before (None) or 24 h after coculture with Mib1
f/f or Mx1-Cre;Mib1
f/f DCs. B, CFSE-labeled naive OT-II CD4
+ T
cells were cultured without (None) or with peptide-pretreated Mib1
f/f or Mx1-Cre;Mib1
f/f DCs, and the activated cells collected on days 1, 2, and 3,
respectively, were stained for CD25 and CD4 and analyzed by flow cytometry. The numbers indicate the percentage of cells within the gates. A
representative of three independent experiments is shown.
doi:10.1371/journal.pone.0036359.g004
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central factor for the differentiation of Th2 cells, and various Th2
cytokines such as IL-4, IL-6, IL-10, and IL-13 were notably
reduced in the CD4
+ T cells cultured with Mib1-null DCs
(Fig. 5D). In contrast, expressions of T-bet, a master regulator of
Th1 differentiation, and Th1 cytokines including IFN-c and TNF-
a were comparable between the CD4
+ T cells stimulated by the
control and Mib1-null DCs (Fig. 5D).
Next, we asked whether the suppression of Th2 differentiation
by Mib1 ablation in DCs is due to an enhanced expression of IFN-
c [35,36]. We treated neutralizing anti-IFN-c Abs during the
CD4
+ T cells and DCs coculture, but the neutralization of IFN-c
could not rescued the impaired Th2 differentiation in CD4
+ T
cells stimulated by Mib1-null DCs (Fig. 6A), ruling out the
possibility of the secondary effect of Notch signaling for the
regulation of Th2 differentiation. To examine the role of Mib1 in
Th differentiation further, we used another TCR-transgenic
mouse model, SMARTA, which expresses a specific TCR for
the lymphocytic choriomeningitis virus epitope GP61–80 [37]. As
shown in Fig. 6B, the frequency of IL-4-expressing cells was lower
in CD4
+ T cells stimulated with Mib1-null DCs than in the control
CD4
+ T cells, implying that defective Th2 differentiation is not
limited to certain TCR transgenic mice. LPS-stimulated DCs have
been known to promote both Th1 and Th2 responses by
expressing Dll and Jag, respectively [6,38]. Unexpectedly,
however, no defects in Th1 differentiation were observed,
suggesting that Th1 differentiation does not require DC-mediated
Notch activation. Overall, we showed that Mib1 deletion in DCs
impaired Th2 differentiation by inactivating Notch signaling in
CD4
+ T cells.
Mib1 in DCs is critical for Th2 induction in vivo
Finally, we used an adoptive transfer strategy to perform an in
vivo experiment by transferring naı ¨ve OT-II CD4
+ T cells and the
control or Mib1-null DCs into CD45.1 congenic mice. Once
again, the specific defect in Th2 differentiation in Mib1-null DCs
was identified, while simultaneously preserving the Th1 responses,
by using intracellular cytokine staining (Fig. 6C and D) and ELISA
analyses (Fig. 6E) to measure IFN-c and IL-4 expressions. In
conclusion, the Mib1 expressed in DCs is a critical regulator of
Notch activation during peripheral immune responses. The
complete inactivation of Notch signaling in DC-CD4
+ T cell
interactions leads to dramatically impaired Th2 differentiation
both in vitro and in vivo. However, there was no evidence of a direct
association between Notch signaling and CD4
+ T cell activation,
proliferation, and Th1 differentiation.
Discussion
Regulation of CD4
+ T cell-mediated immune responses is
crucial for protection against different types of pathogenic
microorganisms as well as peripheral immune tolerance. Espe-
cially, a delicate balance of diverse Th subsets, Th1, Th2, Th17,
and induced regulatory T cells, enables an effective elimination of
dangerous microbes [39]. Although Notch signaling has been
known as one of the mechanisms to regulate Th responses, the
ambiguous role of Notch signaling has hampered any further
clinical application. Previous studies have investigated the role of
Notch signaling by using various experimental approaches,
including overexpression of Notch ligands or NICD, ectopic
manipulation of cytokines, pharmacological inhibition of Notch
signaling by nonselective c-secretase inhibitors, and treatment with
agonistic or antagonistic antibodies [5,7,8,9,10,11,12]. Although
these approaches are convenient and provide many important
cues to reveal the role of Notch signaling, they could result in non-
physiological levels of signaling and unknown side effects that need
to be evaluated using genetic approaches.
The Mib1-null DCs used in this study served as a novel and
reliable genetic model to modulate Notch signaling in CD4
+ T
cells for several reasons. First, Mib1 is dominantly expressed in
DCs and known to play an obligatory role in regulating all Notch
ligands in mice [23]. Indeed, Mib1-null DCs could not activate
Notch signaling in adjacent cells, including CD4
+ T cells, in spite
of the Notch ligands expressions. Thus, the manipulation of Mib1
in DCs efficiently and effectively blocks Notch activation in CD4
+
T cells. Second, using intact naive CD4
+ T cells in both control
and experimental groups, we could exclude the side effects caused
Figure 5. Absence of Mib1 in DCs specifically impairs Th2
differentiation. A, Purified naive OT-II CD4
+ T cells were cultured with
peptide pretreated Mib1
f/f or Mx1-Cre;Mib1
f/f DCs. After 5 days, viable
cells were re-stimulated with PMA and ionomycin for 6 h, and the
intracellular levels of IFN-c and IL-4 were analyzed by flow cytometry.
The numbers indicate the percentage of cells within the gates. A
representative of three independent experiments is shown. B, The
average percentage of activated CD4
+ T cells producing IFN-c and IL-4
(as in [A]) from three independent experiments. C, Viable activated CD4
+
T cells were harvested, and an equal number of cells in each group were
re-stimulated with 1 mg/ml plate-bound anti-CD3. The supernatants
were removed after 48 h, and cytokine concentrations were determined
by ELISA. D, Quantitative real-time RT-PCR analysis of T-bet, Gata-3, Th1
related cytokines (IFN-c and TNF-a), and Th2 related cytokines (IL-4, IL-6,
IL-10, and IL-13) in purified CD4
+ T cells unstimulated (None)o r
stimulated by Mib1
f/f or Mx1-Cre;Mib1
f/f DCs. Data represent mean 6 SD;
*, P,0.05.
doi:10.1371/journal.pone.0036359.g005
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+ T cells and assure their potential
capacity of activation and subset differentiation. Finally yet
importantly, our approach is relevant to the physiological
conditions for CD4
+ T cell immune responses because the
Mib1-null DCs can act as functional APCs, although they could
not activate Notch signaling in the adjacent cells.
In this study, we clearly showed that Mib1 deficiency in DCs
strengthen the Th2-regulating role rather than Th1 for Notch
signaling. In addition, there was no evidence of a regulatory role
for Notch signaling in CD4
+ T cell activation and proliferation,
which is consistent with other studies using independent genetic
approaches, such as RBP-Jk KO [6], Notch1 and Notch2 double
KO [40], and transgenic overexpression of dominant negative
MAML [14]. In a previous study, different Notch ligands, Dll and
Jag on APCs induced Th1 and Th2, respectively, in vitro [6].
However, there is no evidence for ligand type-dependent
regulation of Th differentiation in our approaches, because neither
Jag nor Dll triggered Notch activation in the absence of Mib1.
The modulation of genes related to Notch signaling in APCs,
the signal-sending cells, has not been understood well relative to
that in effector T cells, the signal-receiving cells. We identified that
Mib1 is dominantly expressed in DCs among four Notch-
regulating E3 ligases, and Notch signaling is completely inactivat-
ed solely by Mib1 ablation. Unlike the Notch ligands, interestingly,
Mib1 was highly expressed in DCs prior to antigen stimulation,
enabling DCs to be in ‘ready to go’ state to activate Notch
signaling. However, the molecular mechanism that regulates Mib1
expression during DC development as well as ligands expression
after LPS stimulation has not yet been revealed.
Although recent studies have implicated Notch signaling in the
differentiation and function of other Th subsets, such as Th17 [41]
and induced regulatory T cells [42,43], these roles of Notch
signaling have not been evaluated clearly by using genetic
methods. Further studies are required to reveal the role of Notch
signaling in different types of peripheral immune responses other
than Th1/Th2 differentiation. Here again we expect that our
approach can be applicable to those expanded issues, and even
more reliable than others because we can assure the potential
capacity of Th subset differentiation. Furthermore, our results
suggest that Mib1 is a latent therapeutic target for the regulation of
Notch activation in disorders caused by a predominance of Th2
cell-cytokines, such as allergies, asthma, atopic dermatitis, systemic
lupus erythematosus, and chronic graft-versus-host disease.
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